TickerFacts.

Celcuity Inc. (CELC): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$3.79
Year ended 2025-12-31
2022-12-31: -$2.642023-12-31: -$2.692024-12-31: -$2.832025-12-31: -$3.79-$3.79
2022-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31-$3.79n/m2026-03-26, From 2025-01-01
2024-12-31-$2.83n/m2026-03-26, From 2024-01-01
2023-12-31-$2.69n/m2025-03-31, From 2023-01-01
2022-12-31-$2.64n/a2024-03-27, From 2022-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Celcuity Inc. (CELC)2025-12-31-$3.79n/m
CareDx, Inc. (CDNA)2025-12-31-$0.40n/m
Castle Biosciences Inc (CSTL)2025-12-31-$0.83n/m
BillionToOne, Inc. (BLLN)2025-12-31$0.14n/m
Personalis, Inc. (PSNL)2025-12-31-$0.91n/m
Caris Life Sciences, Inc. (CAI)2025-12-31-$3.22n/m
Veracyte, Inc. (VCYT)2025-12-31$0.82+164.5%
Guardant Health, Inc. (GH)2025-12-31-$3.32n/m
Sera Prognostics, Inc. (SERA)2025-12-31-$0.67n/m

Compare CELC, CDNA, CSTL, BLLN side by side · Screen every company in Services-Medical Laboratories ↗